🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/11/2004 | 41,14 | 42,07 | 39,71 | 41,77 | +2,76% | 5,73% | 171.521 |
| 26/11/2004 | 40,39 | 41,51 | 40,39 | 40,65 | +0,09% | 2,78% | 89.982 |
| 24/11/2004 | 39,04 | 40,65 | 38,89 | 40,61 | +3,33% | 4,51% | 234.920 |
| 23/11/2004 | 40,35 | 41,10 | 38,93 | 39,30 | -3,05% | 5,38% | 255.438 |
| 22/11/2004 | 39,15 | 40,61 | 38,96 | 40,54 | +3,04% | 4,21% | 435.188 |
| 19/11/2004 | 40,12 | 40,61 | 38,59 | 39,34 | -2,32% | 5,04% | 349.454 |
| 18/11/2004 | 39,38 | 40,39 | 38,67 | 40,27 | +2,38% | 4,37% | 247.717 |
| 17/11/2004 | 38,03 | 40,16 | 37,88 | 39,34 | +4,16% | 6,00% | 543.150 |
| 16/11/2004 | 37,06 | 38,85 | 37,06 | 37,77 | +2,75% | 4,85% | 312.077 |
| 15/11/2004 | 34,25 | 37,09 | 34,25 | 36,76 | +8,03% | 8,31% | 326.531 |
| 12/11/2004 | 33,87 | 34,29 | 32,60 | 34,02 | +1,91% | 4,97% | 219.825 |
| 11/11/2004 | 32,19 | 33,42 | 31,67 | 33,39 | +4,33% | 5,47% | 500.964 |
| 10/11/2004 | 31,44 | 33,87 | 30,92 | 32,00 | -10,09% | 9,40% | 1.054.427 |
| 09/11/2004 | 35,60 | 35,90 | 34,73 | 35,60 | +0,11% | 3,26% | 380.178 |
| 08/11/2004 | 34,25 | 35,56 | 33,65 | 35,56 | +3,37% | 5,57% | 194.310 |
| 05/11/2004 | 34,21 | 35,33 | 33,84 | 34,40 | +1,21% | 4,38% | 276.785 |
| 04/11/2004 | 33,20 | 34,10 | 32,75 | 33,99 | +1,79% | 4,06% | 186.269 |
| 03/11/2004 | 33,42 | 34,02 | 32,94 | 33,39 | +3,96% | 3,25% | 135.667 |
| 02/11/2004 | 33,80 | 33,87 | 31,89 | 32,11 | -4,13% | 5,87% | 167.994 |
| 01/11/2004 | 32,98 | 33,91 | 32,86 | 33,50 | +0,34% | 3,18% | 106.332 |
| 29/10/2004 | 33,80 | 34,06 | 32,75 | 33,39 | -1,76% | 3,88% | 124.767 |
| 28/10/2004 | 33,13 | 34,44 | 32,71 | 33,99 | +3,89% | 5,20% | 179.509 |
| 27/10/2004 | 32,26 | 32,94 | 32,11 | 32,71 | +1,04% | 2,55% | 197.196 |
| 26/10/2004 | 32,08 | 32,45 | 31,59 | 32,38 | +0,58% | 2,68% | 128.561 |
| 25/10/2004 | 32,60 | 32,60 | 31,82 | 32,19 | -1,15% | 2,41% | 261.049 |
| 22/10/2004 | 33,42 | 34,06 | 32,41 | 32,56 | -2,58% | 4,93% | 172.510 |
| 21/10/2004 | 32,04 | 33,57 | 32,00 | 33,42 | +4,32% | 4,91% | 326.451 |
| 20/10/2004 | 31,74 | 32,19 | 31,37 | 32,04 | +1,30% | 2,59% | 590.198 |
| 19/10/2004 | 34,14 | 34,29 | 31,63 | 31,63 | -5,90% | 7,79% | 267.808 |
| 18/10/2004 | 32,26 | 33,87 | 31,97 | 33,61 | +4,54% | 5,92% | 351.297 |